Effective trial design need not conflict with good patient care

American Journal of Bioethics

Volumn 2, Issue 2, 2002, Pages 25-26

  Glass, Kathleen Cranley ^a   Waring, Duff ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOCTOR PATIENT RELATION; ETHICS; HUMAN; HUMAN EXPERIMENT; HUMAN RELATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; STANDARD;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ETHICS, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; PHYSICIAN-PATIENT RELATIONS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCHER-SUBJECT RELATIONS;

EID: 0036513940     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651602317533613     Document Type: Note

References (14)

1. Canadian Medical Association (CMA). 1996. Code of ethics. Ottawa: CMA.
2. Freedman, B. 1990. Placebo-controlled trials and the logic of clinical purpose. IRB: A Review of Human Subjects Research 12(6): 1-6.
3. Freedman, B., C. Weijer, and K. C. Glass. 1996a. Placebo orthodoxy in clinical research: Exposing the Myths. I: Empirical and Methodological Myths. Journal of Law, Medicine, and Ethics 24:243-51.
4. Freedman, B. 1996b. Placebo orthodoxy in clinical research: Exposing the myths. II: Ethical, legal and regulatory myths. Journal of Law, Medicine, and Ethics 24:252-59.
5. Giesen, D. 1995. Civil liability of physicians for new methods of treatment or experimentation: A comparative examination. Medical Law Review 3:22-52.
6. Greenberg, R. P., R. F. Bornstein, M. D. Greenberg, and S. Fisher. 1992. A meta-analysis of antidepressant outcome under “blinder” conditions. Journal of Counseling Clinical Psychology 60(5): 664-69.
7. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. 1998. Tri-council policy statement: Ethical conduct for research involving humans. Ottawa: Public Works and Government Services Canada.
8. Moher, D., K. F. Schultz, and D. G. Altman for the CONSORT Group. 2001. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials. Annals of Internal Medicine 134:657-62.
9. Picard, E. I., and G. B. Robertson. 1996. Legal liability of doctors and hospitals in Canada. Scarborough, ON: Carswell.
10. Shapiro, A. K, and W. Shapiro. 1997. The powerful placebo. Baltimore: The Johns Hopkins University Press.
11. Temple, R. 1982. Government viewpoint of clinical trials. Drug Information Journal January/June:10-17.
12. Temple, R. 1996. Problems in interpreting active control equivalence trials. Accountability in Research 4:267-75.
13. Temple, R., and S. S. Ellenberg. 2001. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Annals of Internal Medicine 133:455-63.
14. World Medical Association. 2000. Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284:3043-45.